Drug Device Combination Product Market

Best Price Guarantee	Length	Publisher	Published Date	SKU
from $4,500	278 Pages	Coherent Market Insights	July, 2023	CMI18107829

Best Price Guarantee
Price	from $4,500
Length	278 Pages
Publisher	Coherent Market Insights
Published Date	July, 2023
SKU	CMI18107829

Drug Device Combination Product Market, By Products (Drug Eluting Stents, Transdermal Patches, Infusion Pumps, Drug Eluting Balloon, Inhalers, and Other Products), By Application (Cardiovascular, Diabetes, Cancer Treatment, Respiratory Diseases, and Other Applications), By End User (Hospitals, Ambulatory Surgical Centre’s, and Other End User), and By Region (North America, Latin America, Europe, Asia-Pacific, Middle East and Africa)- Size, Share, Outlook, and Opportunity Analysis, 2023 - 2030

Global drug device combination products are innovative solutions in the field of healthcare that integrate drugs, devices, and/or biological products. These products combine the therapeutic properties of drugs with the functionality of medical devices, resulting in safer and more effective treatments for patients. The combination of drugs and medical devices allows for targeted and precise delivery of medications, enhancing the efficacy of the treatment. For example, drug-eluting stents release medication directly at the site of a blocked artery, promoting faster healing and reducing the risk of restenosis. drug device combination products offer several advantages over traditional therapies. They can simplify treatment regimens by combining multiple therapies into a single product, reducing the burden on patients and healthcare providers. This can lead to improved patient adherence to treatment plans and better health outcomes.

Market Dynamics:

Rise in burden of chronic disorders, growing geriatric population, favorable government policies or initiatives to ensure patient safety, the outbreak of COVID-19 (pandemic), and the introduction of novel products by market players are major factors expected to drive growth of the global drug device combination product market over the forecast period.

For instance, according to the Centers for Disease Control and Prevention (CDC), 6 in 10 people in the U.S. live with at least one chronic disease, such as heart disease and stroke, cancer, or diabetes. These and other chronic diseases are the leading causes of death and disability in the U.S., and they are also a leading driver of health care costs.

Moreover, in October 2020, Medtronic received the U.S. Food and Drug Administration (FDA) approval for the Abre Venous Self-Expanding Stent System. The system is indicated for use in the iliofemoral veins in patients with symptomatic iliofemoral venous outflow obstruction.

Key features of the study:

This report provides in-depth analysis of the global drug device combination product market, and provides market size (US$ Billion) and compound annual growth rate (CAGR %) for the forecast period (2023–2030), considering 2022 as the base year
It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market.
This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players.
It profiles key players in the global drug device combination product market based on the following parameters such as company highlights, products portfolio, key highlights, financial performance, and strategies.
Key companies covered as a part of this study include AbbVie Inc. (Allergan), Terumo Corporation, GlaxoSmithKline PLC, Novartis AG, Medtronic PLC, Abbott Laboratories, Boston Scientific Corp., W L Gore and Associates Inc., Stryker Corporation, and Becton, Dickinson and Company,
Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
The global drug device combination product market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analystsStakeholders would have ease in decision-making through various strategy matrices used in analyzing the global drug device combination product market

Detailed Segmentation:

Global Drug Device Combination Product Market, By Products:
Drug Eluting Stents
Transdermal Patches
Infusion Pumps
Drug Eluting Balloon
Inhalers
Other Products
Global Drug Device Combination Product Market, By Application:
Cardiovascular
Diabetes
Cancer Treatment
Respiratory Diseases
Other Applications
Global Drug Device Combination Product Market, By End User:
Hospitals
Ambulatory Surgical Centers
Other End User
Global Drug Device Combination Product Market, By Region:
North America
U.S.
Canada
Latin America
Brazil
Mexico
Argentina
Rest of Latin America
Europe
Germany
U.K.
France
Italy
Spain
Russia
Rest of Europe
Asia Pacific
China
India
Japan
Australia
South Korea
ASEAN
Rest of Asia Pacific
Middle East & Africa
GCC
Israel
Rest of Middle East
Africa
South Africa
Central Africa
North Africa
Company Profiles:
AbbVie Inc. (Allergan)
Terumo Corporation
GlaxoSmithKline PLC
Novartis AG
Medtronic PLC
Abbott Laboratories
Boston Scientific Corp.
W L Gore and Associates Inc.
Stryker Corporation
Becton, Dickinson and Company

1. Research Objectives and Assumptions: Research Objectives; Assumptions; Abbreviations
2. Market Purview: Report Description; Market Definition and Scope; Executive Summary; Market Snapshot, By Products; Market Snapshot, By Application; Market Snapshot, By End-User; Market Snapshot, By Region; Coherent Opportunity Map (COM)
3. Market Dynamics, Regulations, and Trends Analysis: Market Dynamics; Increase in burden of chronic disorders; Product recalls and associated complications; Outbreak of COVID-19 (global pandemic); Impact Analysis; Key Highlights; Regulatory Scenario; Product launch/Approvals; PEST Analysis; PORTER’s Analysis; Merger and Acquisition Scenario
4. Global Drug Device Combination Product Market– Impact of Coronavirus (COVID-19) Pandemic: COVID-19 Epidemiology; Supply Side and Demand Side Analysis; Economic Impact
5. Global Drug Device Combination Product Market, By Products, 2023-2030, (US$ Bn): Introduction; Market Share Analysis, 2023 and 2030 (%); Y-o-Y Growth Analysis, 2019 - 2030; Segment Trends; Drug Eluting Stents; Introduction; Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Bn); Transdermal Patches; Introduction; Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Bn); Infusion Pumps; Introduction; Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Bn); Drug Eluting Balloon; Introduction; Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Bn); Inhalers; Introduction; Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Bn); Other Products; Introduction; Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Bn)
6. Global Drug Device Combination Product Market, By Application, 2023-2030, (US$ Bn): Introduction; Market Share Analysis, 2023 and 2030 (%); Y-o-Y Growth Analysis, 2019 – 2030; Segment Trends; Cardiovascular; Introduction; Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Bn); Diabetes; Introduction; Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Bn); Cancer Treatment; Introduction; Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Bn); Respiratory Diseases; Introduction; Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Bn); Other Applications; Introduction; Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Bn)
7. Global Drug Device Combination Product Market, By End User, 2023-2030, (US$ Bn): Introduction; Market Share Analysis, 2023 and 2030 (%); Y-o-Y Growth Analysis, 2019 – 2030; Segment Trends; Hospitals; Introduction; Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Bn); Ambulatory Surgical Centers; Introduction; Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Bn); Other Applications; Introduction; Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Bn)
8. Global Drug Device Combination Product Market, By region, 2023-2030, (US$ Bn): Introduction; Market Share Analysis, 2023 and 2030 (%); Y-o-Y Growth Analysis, 2019 – 2030; Segment Trends; North America; Introduction; Market Size and Forecast, and Y-o-Y Growth, By Products Type, 2018 - 2030, (US$ Billion); Market Size and Forecast, and Y-o-Y Growth, By Application, 2018 - 2030, (US$ Billion); Market Size and Forecast, and Y-o-Y Growth, By End User, 2018 – 2030, (US$ Billion); U.S.; Canada; Latin America; Introduction; Market Size and Forecast, and Y-o-Y Growth, By Products Type, 2018 - 2030, (US$ Billion); Market Size and Forecast, and Y-o-Y Growth, By Application, 2018 - 2030, (US$ Billion); Market Size and Forecast, and Y-o-Y Growth, By End User, 2018 – 2030, (US$ Billion); Brazil; Mexico; Argentina; Rest of Latin America; Europe; Introduction; Market Size and Forecast, and Y-o-Y Growth, By Products Type, 2018 - 2030, (US$ Billion); Market Size and Forecast, and Y-o-Y Growth, By Application, 2018 - 2030, (US$ Billion); Market Size and Forecast, and Y-o-Y Growth, By End User, 2018 – 2030, (US$ Billion); U.K.; Germany; Italy; France; Spain; Russia; Rest of Europe; Asia Pacific; Introduction; Market Size and Forecast, and Y-o-Y Growth, By Products Type, 2018 - 2030, (US$ Billion); Market Size and Forecast, and Y-o-Y Growth, By Application, 2018 - 2030, (US$ Billion); Market Size and Forecast, and Y-o-Y Growth, By End User, 2018 – 2030, (US$ Billion); China; India; Japan; ASEAN; Australia; South Korea; Rest of Asia Pacific; Middle East; Introduction; Market Size and Forecast, and Y-o-Y Growth, By Products Type, 2018 - 2030, (US$ Billion); Market Size and Forecast, and Y-o-Y Growth, By Application, 2018 - 2030, (US$ Billion); Market Size and Forecast, and Y-o-Y Growth, By End User, 2018 – 2030, (US$ Billion); GCC; Israel; Rest of Middle East; Africa; Introduction; Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2018-2030,(US$ Billion); Market Size and Forecast, and Y-o-Y Growth, By Application, 2018-2030,( US$ Billion); Market Size and Forecast, and Y-o-Y Growth, By End User, 2018 – 2030, (US$ Million); South Africa; Central Africa; North Africa
9. Competitive Landscape: AbbVie Inc. (Allergan); Company Highlights; Product Portfolio; Key Developments; Financial Performance; Strategies; Terumo Corporation; Company Highlights; Product Portfolio; Key Developments; Financial Performance; Strategies; GlaxoSmithKline PLC; Company Highlights; Product Portfolio; Key Developments; Financial Performance; Strategies; Novartis AG; Company Highlights; Product Portfolio; Key Developments; Financial Performance; Strategies; Medtronic PLC; Company Highlights; Product Portfolio; Key Developments; Financial Performance; Strategies; Abbott Laboratories; Company Highlights; Product Portfolio; Key Developments; Financial Performance; Strategies; Boston Scientific Corp.; Company Highlights; Product Portfolio; Key Developments; Financial Performance; Strategies; W L Gore and Associates Inc.; Company Highlights; Product Portfolio; Key Developments; Financial Performance; Strategies; Stryker Corporation; Company Highlights; Product Portfolio; Key Developments; Financial Performance; Strategies; Becton, Dickinson and Company; Company Highlights; Product Portfolio; Key Developments; Financial Performance; Strategies; Analyst Views
10. Section: Research Methodology; About us; *Browse 40 market data tables and 33 figures on "Global Drug Device Combination Product Market”- forecast to 2030